Patent · US Expired

Adenosine A2a receptor antagonists

US6897216B2 · kind B2 · utility

3Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2003
Grant dateMay 24, 2005
Priority date—
Expiry dateJul 12, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.